124
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Immunogenetics of new onset diabetes after transplantation in Kuwait

, , , , , , & show all
Pages 731-742 | Published online: 20 May 2019

References

  • Ghisdal L , Van Laecke S , Abramowicz MJ , Vanholder R , Abramowicz D . New-onset diabetes after renal transplantation: risk assessment and management. Diabetes Care . 2012;35(1):181–188. doi:10.2337/dc11-1230 22187441
  • Davidson J , Wilkinson A , Dantal J , et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation . 2003;75(10Suppl):SS3–SS24. doi:10.1097/01.TP.0000069952.49242.3E 12775942
  • Chadban S . New-onset diabetes after transplantation – should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients? Nephrol Dial Transplant . 2008;23(6):1816–1818. doi:10.1093/ndt/gfn052 18326882
  • Chadban S , Morris R , Hirsch HH , Bunnapradist S , Arns W , Budde K . Immunosuppression in renal transplantation: some aspects for the modern era. Transplant Rev . 2008;22(4):241–251. doi:10.1016/j.trre.2008.05.003
  • Marcen R , Morales JM , Arias M , et al. Ischemic heart disease after renal transplantation in patients on cyclosporine in Spain. J Am Soc Nephrol . 2006;17(12 Suppl 3):S286–S290. doi:10.1681/ASN.2006080928 17130276
  • Sulanc E , Lane JT , Puumala SE , Groggel GC , Wrenshall LE , Stevens RB . New-onset diabetes after kidney transplantation: an application of 2003 International Guidelines. Transplantation . 2005;80(7):945–952.16249743
  • Aleid H , Alhuraiji A , Alqaraawi A , et al. New-onset diabetes after kidney transplantation: incidence, risk factors, and outcomes. Saudi J Kidney Dis Transpl . 2016;27(6):1155–1161.27900960
  • Al-Daghri NM , Al-Attas OS , Alokail MS , et al. Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC Med . 2011;9:76. doi:10.1186/1741-7015-9-76 21689399
  • Al-Ghareeb SM , El-Agroudy AE , Al Arrayed SM , Al Arrayed A , Alhellow HA . Risk factors and outcomes of new-onset diabetes after transplant: single-centre experience. Exp Clin Transplant . 2012;10(5):458–465. doi:10.6002/ect.2012.0063 22943190
  • Nagib AM , Refaie AF , Akl AI , et al. New onset diabetes mellitus after living donor renal transplantation: a unique pattern in the Egyptian population. J Diabetes Metab . 2015;6(4):1–5.
  • Johny KV , Nampoory MR , Costandi JN , et al. High incidence of post-transplant diabetes mellitus in Kuwait. Diabetes Res Clin Pract . 2002;55(2):123–130.11796178
  • Tarek M , Yagan J , Gheith O , et al. Post transplant diabetes mellitus in Kuwait. Nephrol Dial Transplant . 2017;32(Issue suppl_3):iii275. doi:10.1093/ndt/gfx149.SP451
  • Hecking M , Kainz A , Werzowa J , et al. Glucose metabolism after renal transplantation. Diabetes Care . 2013;36(9):2763–2771. doi:10.2337/dc12-2441 23656979
  • Fabrizi F , Martin P , Dixit V , Bunnapradist S , Kanwal F , Dulai G . Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies. Am J Transplant . 2005;5(10):2433–2440. doi:10.1111/j.1600-6143.2005.01040.x 16162192
  • Kaposztas Z , Gyurus E , Kahan BD . New-onset diabetes after renal transplantation: diagnosis, incidence, risk factors, impact on outcomes, and novel implications. Transplant Proc . 2011;43(5):1375–1394. doi:10.1016/j.transproceed.2011.04.008 21693204
  • Schachtner T , Stein M , Reinke P . Diabetic kidney transplant recipients: impaired infection control and increased alloreactivity. Clin Transplant . 2017;31(7). doi:10.1111/ctr.12986
  • Yates CJ , Fourlanos S , Hjelmesaeth J , Colman PG , Cohney SJ . New-onset diabetes after kidney transplantation-changes and challenges. Am J Transplant . 2012;12(4):820–828. doi:10.1111/j.1600-6143.2011.03855.x 22123607
  • Vincenti F , Friman S , Scheuermann E , et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant . 2007;7(6):1506–1514. doi:10.1111/j.1600-6143.2007.01749.x 17359512
  • Ghisdal L , Bouchta NB , Broeders N , et al. Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature. Transpl Int . 2008;21(2):146–151. doi:10.1111/j.1432-2277.2007.00589.x 17971033
  • Santos AH Jr , Chen C , Casey MJ , Womer KL , Wen X . New-onset diabetes after kidney transplantation: can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology? Nephrol Dial Transplant . 2018;33(1):177–184. doi:10.1093/ndt/gfx281 29045704
  • Cartwright N , Demaine A , Jahromi M , Sanders H , Kaminski ER . A study of cytokine protein secretion, frequencies of cytokine expressing cells and IFN-G gene polymorphisms in normal individuals. Transplantation . 1999;68(10):1546–1552.10589953
  • Jahromi M , Millward A , Demaine A . A CA repeat polymorphism of the IFN-gamma gene is associated with susceptibility to type 1 diabetes. J Interferon Cytokine Res . 2000;20(2):187–190. doi:10.1089/107999000312595 10714554
  • Hayase H , Ishizu A , Ikeda H , et al. Aberrant gene expression by CD25+CD4+ immunoregulatory T cells in autoimmune-prone rats carrying the human T cell leukemia virus type-I gene. Int Immunol . 2005;17(6):677–684. doi:10.1093/intimm/dxh238 15908451
  • Kang K , Park SH , Chen J , et al. Interferon-gamma represses M2 gene expression in human macrophages by disassembling enhancers bound by the transcription factor MAF. Immunity . 2017;47(2):235–250.e234. doi:10.1016/j.immuni.2017.07.017 28813657
  • Pravica V , Asderakis A , Perrey C , Hajeer A , Sinnott PJ , Hutchinson IV . In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet . 1999;26(1):1–3.10068907
  • Pravica V , Perrey C , Stevens A , Lee JH , Hutchinson IV . A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol . 2000;61(9):863–866.11053629
  • Biolo G , Amoroso A , Savoldi S , et al. Association of interferon-gamma +874A polymorphism with reduced long-term inflammatory response in haemodialysis patients. Nephrol Dial Transplant . 2006;21(5):1317–1322. doi:10.1093/ndt/gfk033 16410273
  • Shiu KY , McLaughlin L , Rebollo-Mesa I , et al. Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-gamma production by Th1 cells. Kidney Int . 2017;91(2):477–492. doi:10.1016/j.kint.2016.10.009 27988211
  • Kidney Disease: Improving Global Outcomes Transplant Work G. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant . 2009;9 Suppl 3:S1–S155.
  • Baker RJ , Mark PB , Patel RK , Stevens KK , Palmer N . Renal association clinical practice guideline in post-operative care in the kidney transplant recipient. BMC Nephrol . 2017;18(1):174. doi:10.1186/s12882-017-0669-4 28571571
  • Kasiske BL , Snyder JJ , Gilbertson D , Matas AJ . Diabetes mellitus after kidney transplantation in the United States. Am J Transplant . 2003;3(2):178–185.12603213
  • Billiau A . Interferon-gamma: biology and role in pathogenesis. Adv Immunol . 1996;62:61–130.8781267
  • Adamopoulos S , Kolokathis F , Gkouziouta A , et al. Cytokine gene polymorphisms are associated with markers of disease severity and prognosis in patients with idiopathic dilated cardiomyopathy. Cytokine . 2011;54(1):68–73. doi:10.1016/j.cyto.2011.01.004 21282066
  • Raisanen-Sokolowski A , Glysing-Jensen T , Koglin J , Russell ME . Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients. Am J Pathol . 1998;152(2):359–365.9466561
  • Kim HJ , Kang SW , Chung JH , Kim SJ , Choe BK . Polymorphisms of the Interferon gamma gene and coronary artery disease in the Korean population. Mol Biol Rep . 2012;39(5):5425–5432. doi:10.1007/s11033-011-1342-9 22189538
  • Babu BM , Reddy BP , Priya VH , et al. Cytokine gene polymorphisms in the susceptibility to acute coronary syndrome. Genet Test Mol Biomarkers . 2012;16(5):359–365. doi:10.1089/gtmb.2011.0182 22372709
  • Puoti F , Ricci A , Nanni-Costa A , Ricciardi W , Malorni W , Ortona E . Organ transplantation and gender differences: a paradigmatic example of intertwining between biological and sociocultural determinants. Biol Sex Differ . 2016;7:35. doi:10.1186/s13293-016-0088-4 27471591
  • Pham PT , Pham PM , Pham SV , Pham PA , Pham PC . New onset diabetes after transplantation (NODAT): an overview. Diabetes Metab Syndr Obes . 2011;4:175–186. doi:10.2147/DMSO.S19027 21760734
  • Yi Z , Li L , Garland A , et al. IFN-gamma receptor deficiency prevents diabetes induction by diabetogenic CD4+, but not CD8+, T cells. Eur J Immunol . 2012;42(8):2010–2018. doi:10.1002/eji.201142374 22865049
  • Babel N , Cherepnev G , Kowalenko A , Horstrup J , Volk HD , Reinke P . Nonimmunologic complications and gene polymorphisms of immunoregulatory cytokines in long-term renal transplants. Kidney Int . 2004;66(1):428–432. doi:10.1111/j.1523-1755.2004.00749.x 15200452
  • Oxenkrug G . Interferon-gamma – inducible inflammation: contribution to aging and aging-associated psychiatric disorders. Aging Dis . 2011;2(6):474–486.22396896
  • Franceschi C , Bonafe M , Valensin S , et al. Inflamm-aging: an evolutionary perspective on immunosenescence. Ann N Y Acad Sci . 2000;908:244–254.10911963
  • Shanley DP , Aw D , Manley NR , Palmer DB . An evolutionary perspective on the mechanisms of immunosenescence. Trends Immunol . 2009;30(7):374–381. doi:10.1016/j.it.2009.05.001 19541538
  • Singh P , Goode T , Dean A , Awad SS , Darlington GJ . Elevated interferon gamma signaling contributes to impaired regeneration in the aged liver. J Gerontol A Biol Sci Med Sci . 2011;66(9):944–956. doi:10.1093/gerona/glr094 21719609
  • Nosratabadi R , Arababadi MK , Hassanshahi G , et al. Evaluation of IFN-gamma serum level in nephropatic type 2 diabetic patients. Pak J Biol Sci . 2009;12(9):746–749.19634484
  • Mahmoud A , Sheneef A , Goda A , Ismail M , Abualfadl E . Association of interferon-cand its (+874 T/A)gene polymorphism with type 2 diabetes mellitus inrheumatoid arthritis patients. Egypt Rheumatol . 2015;38(4).
  • Nicolau J , Lequerré T , Bacquet H , Vittecoq O . Rheumatoid arthritis, insulin resistance, and diabetes. Joint Bone Spine . 2017;84(4):411–416. doi:10.1016/j.jbspin.2016.09.001 27777170
  • Tsiavou A , Hatziagelaki E , Chaidaroglou A , Koniavitou K , Degiannis D , Raptis SA . Correlation between intracellular interferon-gamma (IFN-gamma) production by CD4+ and CD8+ lymphocytes and IFN-gamma gene polymorphism in patients with type 2 diabetes mellitus and latent autoimmune diabetes of adults (LADA). Cytokine . 2005;31(2):135–141. doi:10.1016/j.cyto.2005.02.011 15935691
  • Zhu QR , Ge YL , Gu SQ , et al. Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. Chin Med J (Engl) . 2005;118(19):1604–1609.16232344
  • Zambon CF , Basso D , Navaglia F , et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine . 2005;29(4):141–152. doi:10.1016/j.cyto.2004.10.013 15652446
  • Morrison BA , Ucisik-Akkaya E , Flores H , Alaez C , Gorodezky C , Dorak MT . Multiple sclerosis risk markers in HLA-DRA, HLA-C, and IFNG genes are associated with sex-specific childhood leukemia risk. Autoimmunity . 2010;43(8):690–697. doi:10.3109/08916930903567492 21067287
  • Mukhtar NA , Ayala C , Maher JJ , Khalili M . Assessment of factors associated with pre-diabetes in HCV infection including direct and dynamic measurements of insulin action. J Viral Hepat . 2012;19(7):480–487. doi:10.1111/j.1365-2893.2011.01568.x 22676360
  • Liang J , Lv C , Chen M , et al. Effects of preoperative hepatitis B virus infection, hepatitis C virus infection, and coinfection on the development of new-onset diabetes after kidney transplantation. J Diabetes . 2018. doi:10.1111/1753-0407.12853
  • Klein S . Host factors mediating sex differences in viral infection. Gend Med . 2005;2(4):197–207.16464732
  • Esmaeili A , Mirzazadeh A , Carter GM , et al. Higher incidence of HCV in females compared to males who inject drugs: a systematic review and meta-analysis. J Viral Hepat . 2017;24(2):117–127. doi:10.1111/jvh.12628 27790803
  • Youssef SS , Abd El Aal AM , Nasr AS , El Zanaty T , Seif SM . Interleukin-12B gene polymorphism frequencies in Egyptians and sex-related susceptibility to hepatitis C infection. J Interferon Cytokine Res . 2013;33(8):415–419. doi:10.1089/jir.2012.0161 23600862
  • Ruggieri A , Gagliardi MC , Anticoli S . Sex-dependent outcome of hepatitis B and C viruses infections: synergy of sex hormones and immune responses? Front Immunol . 2018;9:2302. doi:10.3389/fimmu.2018.02302 30349537
  • Hjelmesaeth J , Sagedal S , Hartmann A , et al. Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia . 2004;47(9):1550–1556. doi:10.1007/s00125-004-1499-z 15338129
  • Sinangil A , Celik V , Barlas S , et al. The incidence of new onset diabetes after transplantation and related factors: single center experience. Nefrologia . 2017;37(2):181–188. doi:10.1016/j.nefro.2016.11.022 28262264
  • Marin M , Renoult E , Bondor CI , Kessler M . Factors influencing the onset of diabetes mellitus after kidney transplantation: a single French center experience. Transplant Proc . 2005;37(4):1851–1856. doi:10.1016/j.transproceed.2005.03.140 15919484
  • Dedinska I , Laca L , Miklusica J , Kantarova D , Galajda P , Mokan M . Correlation between CMV infection and post-transplantation new-onset diabetes mellitus. Int J Organ Transplant Med . 2016;7(3):173–182.27721964
  • Miles AM , Sumrani N , Horowitz R , et al. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Transplantation . 1998;65(3):380–384.9484755
  • Hjelmesaeth J , Hartmann A , Leivestad T , et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int . 2006;69(3):588–595. doi:10.1038/sj.ki.5000116 16395250
  • Yu H , Kim H , Baek CH , et al. Risk factors for new-onset diabetes mellitus after living donor kidney transplantation in Korea – a retrospective single center study. BMC Nephrol . 2016;17(1):106. doi:10.1186/s12882-016-0321-8 27473469
  • Kuypers DR , Claes K , Bammens B , Evenepoel P , Vanrenterghem Y . Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM). Nephrol Dial Transplant . 2008;23(6):2033–2042. doi:10.1093/ndt/gfm875 18174264
  • Rodrigo E , Santos L , Pinera C , et al. Early prediction of new-onset diabetes mellitus by fifth-day fasting plasma glucose, pulse pressure, and proteinuria. Transplant Proc . 2011;43(6):2208–2210. doi:10.1016/j.transproceed.2011.05.005 21839235
  • Rodrigo E , Santos L , Pinera C , et al. Prediction at first year of incident new-onset diabetes after kidney transplantation by risk prediction models. Diabetes Care . 2012;35(3):471–473. doi:10.2337/dc11-2071 22279030
  • Muhlhauser I , Berger M . Evidence-based patient information in diabetes. Diabetic Med . 2000;17(12):823–829.11168323
  • Knobler H , Stagnaro-Green A , Wallenstein S , Schwartz M , Roman SH . Higher incidence of diabetes in liver transplant recipients with hepatitis C. J Clin Gastroenterol . 1998;26(1):30–33.9492860